The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Mar. 08, 2022

Filed:

Oct. 26, 2017
Applicant:

Icahn School of Medicine AT Mount Sinai, New York, NY (US);

Inventors:

Andrew F. Stewart, New York, NY (US);

Peng Wang, Fresh Meadows, NY (US);

Assignee:
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 31/47 (2006.01); A61K 31/44 (2006.01); A61K 31/425 (2006.01); A61K 31/40 (2006.01); A61K 31/519 (2006.01); A61P 1/18 (2006.01); A61P 3/10 (2006.01); A61K 31/4045 (2006.01); A61K 31/428 (2006.01); A61K 31/437 (2006.01); A61K 31/454 (2006.01); A61K 31/4709 (2006.01); C12N 5/071 (2010.01);
U.S. Cl.
CPC ...
A61K 31/519 (2013.01); A61K 31/4045 (2013.01); A61K 31/428 (2013.01); A61K 31/437 (2013.01); A61K 31/454 (2013.01); A61K 31/4709 (2013.01); A61P 1/18 (2018.01); A61P 3/10 (2018.01); C12N 5/0676 (2013.01); C12N 2501/999 (2013.01);
Abstract

The present invention relates to a method of increasing cell proliferation in a population of pancreatic beta cells and a method of treating a subject for a condition associated with an insufficient level of insulin secretion. Also disclosed is a composition. The composition includes a dual-specificity tyrosine phosphorylation-regulated kinase 1A (DYRK1 A) inhibitor and a transforming growth factor beta (TGFP) superfamily signaling pathway inhibitor.


Find Patent Forward Citations

Loading…